Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice

Nature Medicine

Volumn 2, Issue 9, 1996, Pages 998-1004

  Neurath, Markus F ^a   Pettersson, Sven ^b   Meyer Zum Buschenfelde, Karl Hermann ^a   Strober, Warren ^c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CORTICOSTEROID; MESALAZINE; PREDNISOLONE; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; FEMALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CROHN DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; DNA; ENTEROCOLITIS; FEMALE; HUMANS; INTERLEUKIN-10; MALE; MICE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NF-KAPPA B; OLIGONUCLEOTIDES, ANTISENSE; TRANSCRIPTION FACTOR RELA; TRINITROBENZENESULFONIC ACID;

ANIMALIA;

EID: 0029836444     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0996-998     Document Type: Article

References (47)

1. Podolsky, D.K Inflammatory bowel disease. N. Engl. J. Med. 325, 928-935 (1995).
2. Strober, W. & Neurath, M.F. Immunological diseases of the gastrointestinal tract. in Clinical Immunology (ed. Rich, R.R.) 1401-1428 (Mosby, St. Louis, 1995).
3. Strober, W. & Ehrhardt, R.O. Chronic intestinal inflammation: an unexpected outcome on cytokine or T cell receptor mutant mice. Cell 75, 203-205 (1993).
4. Hammer, R.E. et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: An animal model of HLAB-27-associated human disorders. Cell 63, 1099-1112 (1990)
5. Hermiston, M L. & Gordon, J I Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270, 1203-1207 (1995)
6. Hollander, G.A et al. Severe colitis in mice with aberrant thymic selection. Immunity 3, 27-38 (1995).
7. Sadlack, B. et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253-261 (1993)
8. Kühn, R., Lohler, J., Rennick, D., Rajewsky, K & Müller, W Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993).
9. 12-deficient mice Nature Genet. 10, 143-146 (1995).
10. Mombaerts, P et al. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75, 275-282 (1993).
11. + T cells. Immunity 1, 553-562 (1994).
12. Neurath, M.F., Fuss, I., Kelsall, B L., Stuber, E. & Strober, W. Antibodies to IL-12 abrogate established experimental colitis in mice. J. Exp. Med 182, 1280-1289 (1995).
13. Stuber, E., Strober, W. & Neurath, M.F. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of Th1-T cells through the inhibition of IL-12 secretion. J Exp. Med. 183, 693-698 (1996).
14. Cross, S L. et al. Functionally distinct NF-κB binding sites in the Ig kappa and IL-2 receptor alpha chain genes Science 244, 466-469 (1989).
15. Finco, T.S. & Baldwin, A S. Mechanistic aspects of NF-κB regulation The emerging role of phosphorylation and proteolysis. Immunity 3, 263-272 (1995)
16. Lenardo, M J. & Baltimore, D. NF-κB: A pleiotropic activator of inducible and tissue specific gene control. Cell 58, 227-237 (1989).
17. Baeuerle, P.A. & Henkel, T. Function and activation of NF-κB in the immune system. Annu Rev. Immunol. 12, 141-179 (1994).
18. Sha, W et al Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80, 321-330 (1995).
19. Weih, F et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80, 331-340 (1995).
20. Kontgen, F et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9, 1965-1977 (1995).
21. Burkly, L. et al. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373, 531-536 (1995)
22. Shakhov, A N. et al. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages J. Exp. Med 171, 35-47 (1990).
23. Libermann, T.A. & Baltimore, D Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell Biol. 10, 2327-2334 (1990).
24. Higgins, K.A. et al. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. USA 90, 9901-9905 (1993)
25. Kitajima, I. et al Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science 258, 1792-1795 (1992).
26. Krieg, A M CpG motifs in bacterial DNA trigger direct B cell activation. Nature 374, 546-549 (1995).
27. Loke, S L et al. Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematapoietic cells in culture by liposome fusion Specific reduction in c-Myc protein expression correlates with inhibition of cell growth and DNA synthesis. Curr Top. Microbiol. Immunol 141, 282-288 (1988).
28. Venturelli, D., Travali, S & Calabretta, B Inhibition of T-cell proliferation of a Myb antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression. Proc. Natl. Acad Sci USA 87, 5963-5967 (1990).
29. Voltieri, M. et al. Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cyclin activity and expression of DNA polymerase alpha. Blood 77, 1181-1190 (1991).
30. Holt, J.T. et al. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc. Natl Acad. Sci. USA 83, 4794-4798 (1986).
31. Nishikura, K. & Murray, J M. Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells. Mol. Cell. Biol. 7, 639-648 (1987)
32. Wakatsuki, Y., Neurath, M.F., Max, E.E. & Strober, W. The B cell specific transcription factor BSAP regulates B cell proliferation. J. Exp. Med. 179, 1099-1108 (1994)
33. Gura, T. Antisense has growing pains. Science 270, 575-577 (1995).
34. Wagner, R.W et al Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines Science 260, 1510-1514 (1993)
35. Wagner, R.W. Gene inhibition using antisense oligodeoxynucleotides. Nature 372, 333-335 (1994).
36. Nesterova, M & Cho-Chung Y.S. A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth. Nature Med. 1, 528-533 (1995).
37. Holt, J T. A 'senseless' immune response to DNA. Nature Med. 1, 407-408 (1995)
38. Wrighton, C.J et al. Inhibition of endothelial cell activation by adenovirus-mediated expression of IκBα, an inhibitor of the transcription factor NF-κB. J. Exp. Med. 183, 1013-1022 (1996).
39. van Dullemen, H M. et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109, 129-135 (1995).
40. Sartor, R B Role of intestinal microflora in initiation and perpetuation of inflammatory bowel disease. Can. J Gastroenterol 4, 271-277 (1990).
41. Duchmann, R , Schmitt, E., Knolle, P., Meyer zum Büschenfelde, K.-H. & Neurath, M.F. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12 Eur J. Immunol. 26, 934-938 (1996).
42. Wang, P , Wu, P., Siegel, M.I., Egan, R.W. & Billah, M M. Interleukin (IL)-10 inhibits nuclear factor B (NF kappa B) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270, 9558-9563 (1995).
43. Scheinman, R.I., Cogswell, P.C., Lofquist, A.K. & Baldwin, A.S. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270, 283-286 (1995).
44. Auphan, N , DiDonato, J.A., Rosette, C., Helmberg, A. & Karin, M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκBα synthesis. Science 270, 286-290 (1995).
45. Neurath, M.F., Max E.E & Strober W. Pax5 (BSAP) regulates the murine immunoglobulin 3′α enhancer by affecting binding of NF-αP, a protein that controls heavy chain transcription Proc Natl Acad. Sci. USA 92, 5336-5340 (1995).
46. Demczuk, S , Harbers, M. & Vennstrom, B Identification and analysis of all components of a gel retardation assay by combination with immunoblotting. Proc. Natl. Acad. Sci. USA 90, 2574-2578 (1993).
47. Bull, D.M. & Bookman, M A Isolation and functional characterization of human intestinal mucosal mononuclear cells. J. Clin. Invest. 59, 966-974 (1977).